An update on allopurinol and kidney failure; new trend for an old drug

Allopurinol is an inhibitor of xanthine oxidase (XO) enzyme. This drug is a reducer of uric acid in the body and one of the golden drugs with worldwide administration. XO is an important biological source of free radical generation. Allopurinol as an antioxidant, has direct and indirect antioxidant activity on these free radicals such as hydroxyl radical and superoxide anion. The purpose of this paper is to determine the impact of allopurinol on some aspects of renal disturbances such as renal ischemia/reperfusion injury (IRI), nephrotoxicity and contrast-induced nephropathy (CIN).

[1]  J. Crowell,et al.  Effect of allopurinol on hemorrhagic shock. , 1969, The American journal of physiology.

[2]  Jones Ce,et al.  Effect of allopurinol on hemorrhagic shock , 1969 .

[3]  R. Dewall,et al.  Effect of allopurinol in renal ischemia. , 1972, Surgery.

[4]  M. Owens,et al.  Allopurinol and hypoxanthine pretreatment of canine kidney donors. , 1974, Transplantation.

[5]  T. Keaveny,et al.  Effect of allopurinol on tissue ATP, ADP and AMP concentrations in renal ischaemia , 1974, The British journal of surgery.

[6]  G. Baker,et al.  Effect of allopurinol on kidneys after ischemia and reperfusion. , 1985, Current surgery.

[7]  T. Scherstén,et al.  Kidney protection by pretreatment with free radical scavengers and allopurinol: renal function at recirculation after warm ischaemia in rabbits. , 1986, Clinical science.

[8]  [Reduction of renal reperfusion damage following warm ischemia by allopurinol and superoxide dismutase]. , 1989, Helvetica chirurgica acta.

[9]  A. Augustin,et al.  Free radical scavenging and antioxidant activity of allopurinol and oxypurinol in experimental lens-induced uveitis. , 1994, Investigative ophthalmology & visual science.

[10]  A. Aricioglu,et al.  The effect of allopurinol on Na+K+ATPase related lipid peroxidation in ischemic and reperfused rabbit kidney. , 1994, General pharmacology.

[11]  Allopurinol fails to protect against gentamicin-induced renal damage in normotensive and spontaneously hypertensive rats. , 1994, Nephron.

[12]  P. Rolfe,et al.  Is allopurinol beneficial in the prevention of renal ischaemia-reperfusion injury in the rat?: evaluation by near-infrared spectroscopy. , 1995, Clinical science.

[13]  [Effects of allopurinol on renal damage following renal ischemia]. , 1995, Masui. The Japanese journal of anesthesiology.

[14]  M. Inal,et al.  Beneficial Effects of Allopurinol on Glutathione Levels and Glutathione Peroxidase Activity in Rat Ischaemic Acute Renal Failure , 1996, The Journal of international medical research.

[15]  [Effects of allopurinol for oxidative injury of cisplatin-induced nephrotoxicity in mice]. , 1999, Yakugaku zasshi : Journal of the Pharmaceutical Society of Japan.

[16]  Y. Nergiz,et al.  Potentiation of cisplatin-induced nephrotoxicity in rats by allopurinol. , 2000, Experimental and toxicologic pathology : official journal of the Gesellschaft fur Toxikologische Pathologie.

[17]  A. Belló-Klein,et al.  Protective effect of allopurinol in the renal ischemia--reperfusion in uninephrectomized rats. , 2000, General pharmacology.

[18]  K. Leung,et al.  Use of allopurinol in slowing the progression of renal disease through its ability to lower serum uric acid level. , 2006, American journal of kidney diseases : the official journal of the National Kidney Foundation.

[19]  Ulutaş Bülent,et al.  Unable to protect gentamicin-induced nephrotoxicity with allopurinol in rats , 2006 .

[20]  Z. Miloradović,et al.  Allopurinol and Enalapril Failed to Conserve Urinary NOx and Sodium in Ischemic Acute Renal Failure in Spontaneously Hypertensive Rats , 2006, American Journal of Nephrology.

[21]  C. Szabó,et al.  Therapeutic Effects of Xanthine Oxidase Inhibitors: Renaissance Half a Century after the Discovery of Allopurinol , 2006, Pharmacological Reviews.

[22]  K. Nugent,et al.  Cisplatin Nephrotoxicity: A Review , 2007, The American journal of the medical sciences.

[23]  N. Patel,et al.  Nitrite-derived nitric oxide protects the rat kidney against ischemia/reperfusion injury in vivo: role for xanthine oxidoreductase. , 2007, Journal of the American Society of Nephrology : JASN.

[24]  O. Baskurt,et al.  The effects of renal ischemia-reperfusion on hemorheological factors: preventive role of allopurinol. , 2007, Clinical hemorheology and microcirculation.

[25]  M. Goicoechea,et al.  Effect of allopurinol in chronic kidney disease progression and cardiovascular risk. , 2010, Clinical journal of the American Society of Nephrology : CJASN.

[26]  E. Falkenstein,et al.  Effects of allopurinol on uric acid concentrations, xanthine oxidoreductase activity and oxidative stress in broiler chickens. , 2010, Comparative biochemistry and physiology. Toxicology & pharmacology : CBP.

[27]  Y. Caliskan,et al.  Reduction of uric acid levels with allopurinol treatment improves endothelial function in patients with chronic kidney disease. , 2012, Clinical nephrology.

[28]  Qing-Yu Zhang,et al.  Quercetin and Allopurinol Ameliorate Kidney Injury in STZ-Treated Rats with Regulation of Renal NLRP3 Inflammasome Activation and Lipid Accumulation , 2012, PloS one.

[29]  Isoprostane: quantitation of renal ischemia and reperfusion injury after renal artery clamping in an animal model. , 2012, Journal of endourology.

[30]  Benjamin R. Lee,et al.  Protective effects of reducing renal ischemia-reperfusion injury during renal hilar clamping: use of allopurinol as a nephroprotective agent. , 2013, Urology.

[31]  T. Erol,et al.  Efficacy of allopurinol pretreatment for prevention of contrast-induced nephropathy: a randomized controlled trial. , 2013, International journal of cardiology.

[32]  L. Toledo-Pereyra,et al.  Allopurinol in Renal Ischemia , 2014, Journal of investigative surgery : the official journal of the Academy of Surgical Research.

[33]  D. Choi,et al.  Association of preoperative uric acid and acute kidney injury following cardiovascular surgery. , 2014, Journal of cardiothoracic and vascular anesthesia.

[34]  H. Orhan,et al.  The effects of allopurinol on metabolic acidosis and endothelial functions in chronic kidney disease patients , 2015, Clinical and Experimental Nephrology.

[35]  Ashutosh Kumar,et al.  Comparative study of renal protective effects of allopurinol and N-acetyl-cysteine on contrast induced nephropathy in patients undergoing cardiac catheterization. , 2014, Journal of clinical and diagnostic research : JCDR.

[36]  S. Sharma,et al.  Lowering Uric Acid With Allopurinol Improves Insulin Resistance and Systemic Inflammation in Asymptomatic Hyperuricemia , 2015, Journal of Investigative Medicine.

[37]  Abhinav Sharma,et al.  Involvement of oxidative stress in patients of gout and antioxidant effect of allopurinol , 2015 .

[38]  K. Kwak,et al.  Effects of Allopurinol and Apocynin on Renal Ischemia-Reperfusion Injury in Rats. , 2015, Transplantation proceedings.

[39]  P. Liu,et al.  Allopurinol treatment improves renal function in patients with type 2 diabetes and asymptomatic hyperuricemia: 3‐year randomized parallel‐controlled study , 2015, Clinical endocrinology.

[40]  Y. Qing,et al.  Associations Between Hyperuricemia and Chronic Kidney Disease: A Review , 2015, Nephro-urology monthly.

[41]  S. Rocha,et al.  Dose-Dependent Effects of Allopurinol on Human Foreskin Fibroblast Cells and Human Umbilical Vein Endothelial Cells under Hypoxia , 2015, PloS one.